About 30-40% of premature births are caused by the ruptures of the amnion.
This is associated with a substantial increase in the risk of maternal and
fetal morbidity and mortality. The biochemical processes within the amnion
which are relevant to preterm rupture are becoming increasingly better unde
rstood. Ascending infections from the vagina seem to be one of the main fac
tors leading to premature amniotic rupture.
The diagnosis of both preterm ruptures as well as of potentially underlying
intrauterine infections may be difficult. Early verification is, however,
mandatory for further clinical management. Antenatal glucocorticoid applica
tion is one of the few extensively investigated therapies and the systemic
application of antibiotics also seems to have advantages.